Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

Screentec Signals Discovery Ambitions With Name Change

May 8, 2002

By Cormac Sheridan

Screentec Signals Discovery Ambitions With Name Change

May 8, 2002

By Cormac Sheridan

Personal Chemistry Purchases ESyTech To Extend Platform

May 8, 2002

By Cormac Sheridan

Swiss Firm Axovan Raises CHF30M In Second Round

May 1, 2002

By Cormac Sheridan

Newron Raises EUR18.5 Million In Second Round For CNS Drugs

May 1, 2002

By Cormac Sheridan

Glaucus Proteomics Logs On To Dutch Supercomputing Facility

May 1, 2002

By Cormac Sheridan

NeuroSearch Stops Development Of NS3728 For Sickle-Cell Anemia

May 1, 2002

By Cormac Sheridan

Newron Raises EUR18.5 Million In Second Round For CNS Drugs

May 1, 2002

By Cormac Sheridan

Swiss Firm Axovan Raises CHF30M In Second Round

May 1, 2002

By Cormac Sheridan

Glaucus Proteomics Logs On To Dutch Supercomputing Facility

May 1, 2002

By Cormac Sheridan

View All Articles by Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...